Simple diagnostic tests empowering myeloma patients
Paid and presented by SkylineDX.
The advent of precision medicine is a defining moment for healthcare, making personalised patient care a reality. Jenny was diagnosed with multiple myeloma 10 years ago and, like a small proportion of patients with the condition, she's at high risk of relapse and aggressive disease progression. Here's how simple prognostic diagnostic tests, and data provided by organisations such as SparkCures, can enable delivery of more information to further individualise treatment and empower patients to take a more active role in their disease management.